|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
61,660,000 |
Market
Cap: |
46.94(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6394 - $5.57 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AlloVir is a late clinical-stage cell therapy company developing allogeneic T-cell therapies to treat and prevent devastating viral diseases. Co.'s Pipeline includes: Posoloeucel, which is an allogeneic, off-the-shelf virus-specific T cell (VST) therapy candidate targeting adenovirus, BK virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus that can lead to devastating viral disease in the allogeneic hematopoietic cell transplant population; and ALVR106, which is an allogeneic, off-the-shelf VST therapy candidate developed to target devastating diseases caused by human metapneumovirus, influenza, parainfluenza virus and respiratory syncytial virus.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
2,930,870 |
2,930,870 |
Total Buy Value |
$0 |
$0 |
$10,990,763 |
$10,990,763 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
49,815 |
194,004 |
265,777 |
1,488,473 |
Total Sell Value |
$38,529 |
$137,285 |
$313,570 |
$9,885,249 |
Total People Sold |
4 |
4 |
4 |
7 |
Total Sell Transactions |
20 |
39 |
62 |
109 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brainard Diana |
Chief Executive Officer |
|
2024-04-02 |
4 |
S |
$0.77 |
$1,183 |
D/D |
(1,533) |
812,536 |
|
1% |
|
Sinha Vikas |
See Remarks |
|
2024-04-02 |
4 |
S |
$0.77 |
$683 |
D/D |
(885) |
1,141,474 |
|
1% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-02-21 |
4 |
S |
$0.71 |
$3,650 |
D/D |
(5,155) |
814,069 |
|
-7% |
|
Sinha Vikas |
See Remarks |
|
2024-02-20 |
4 |
S |
$0.70 |
$2,011 |
D/D |
(2,893) |
1,142,359 |
|
-8% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-02-20 |
4 |
S |
$0.70 |
$343 |
D/D |
(494) |
78,853 |
|
-8% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-02-20 |
4 |
S |
$0.70 |
$2,153 |
D/D |
(3,097) |
819,224 |
|
-8% |
|
Miller Edward |
General Counsel |
|
2024-02-20 |
4 |
S |
$0.70 |
$268 |
D/D |
(385) |
224,978 |
|
-8% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-02-08 |
4 |
S |
$0.67 |
$7,494 |
D/D |
(11,150) |
79,347 |
|
-13% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-02-05 |
4 |
S |
$0.67 |
$27,752 |
D/D |
(41,421) |
822,321 |
|
-13% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-02-05 |
4 |
S |
$0.67 |
$3,881 |
D/D |
(5,792) |
90,497 |
|
-13% |
|
Sinha Vikas |
See Remarks |
|
2024-02-05 |
4 |
S |
$0.67 |
$12,282 |
D/D |
(18,331) |
1,145,252 |
|
-13% |
|
Miller Edward |
General Counsel |
|
2024-02-05 |
4 |
S |
$0.67 |
$5,942 |
D/D |
(8,869) |
225,363 |
|
-13% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-01-23 |
4 |
S |
$0.67 |
$6,369 |
D/D |
(9,500) |
863,742 |
|
-11% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-01-23 |
4 |
S |
$0.67 |
$604 |
D/D |
(901) |
96,289 |
|
-11% |
|
Sinha Vikas |
See Remarks |
|
2024-01-23 |
4 |
S |
$0.67 |
$2,150 |
D/D |
(3,205) |
1,163,583 |
|
-11% |
|
Miller Edward |
General Counsel |
|
2024-01-23 |
4 |
S |
$0.67 |
$873 |
D/D |
(1,302) |
234,232 |
|
-11% |
|
Miller Edward |
General Counsel |
|
2024-01-04 |
4 |
S |
$0.64 |
$271 |
D/D |
(424) |
235,534 |
|
-12% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-01-04 |
4 |
S |
$0.64 |
$1,063 |
D/D |
(1,664) |
873,242 |
|
-12% |
|
Sinha Vikas |
See Remarks |
|
2024-01-04 |
4 |
S |
$0.64 |
$614 |
D/D |
(961) |
1,166,788 |
|
-12% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-01-04 |
4 |
S |
$0.64 |
$198 |
D/D |
(310) |
97,190 |
|
-12% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2023-12-27 |
4 |
S |
$0.74 |
$20,838 |
D/D |
(28,335) |
97,500 |
|
-12% |
|
Brainard Diana |
Chief Executive Officer |
|
2023-11-20 |
4 |
S |
$1.69 |
$7,408 |
D/D |
(4,382) |
874,906 |
|
53% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2023-11-17 |
4 |
S |
$1.63 |
$657 |
D/D |
(403) |
125,835 |
|
51% |
|
Brainard Diana |
Chief Executive Officer |
|
2023-11-17 |
4 |
S |
$1.63 |
$4,386 |
D/D |
(2,689) |
879,288 |
|
51% |
|
Sinha Vikas |
See Remarks |
|
2023-11-17 |
4 |
S |
$1.63 |
$4,061 |
D/D |
(2,490) |
1,167,749 |
|
51% |
|
304 Records found
|
|
Page 2 of 13 |
|
|